HIGHLIGHTS
- who: Mirko Manchia et al. from the Unit of Psychiatry, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy have published the research: Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders, in the Journal: (JOURNAL) of 19/Oct/2022
- what: The authors aimed at testing the association of BDNF serum levels with several demographic clinical and psychometric measures in 105 patients with SCZ and SAD assessing the moderating effect of genetic variants within the BDNF gene. The secondary aim of the study was to examine if . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.